Literature DB >> 13680126

A high carbohydrate diet does not induce hyperglycaemia in a mitochondrial glycerol-3-phosphate dehydrogenase-deficient mouse.

A Barberà1, M Gudayol, K Eto, H Corominola, P Maechler, O Miró, F Cardellach, R Gomis.   

Abstract

AIMS/HYPOTHESIS: The electrons of the glycolysis-derived reduced form of NADH are transferred to mitochondria through the NADH shuttle system. There are two NADH shuttles: the glycerol phosphate and malate-aspartate shuttle. Mice with a targeted disruption of mitochondrial glycerol-3-phosphate dehydrogenase, a rate-limiting enzyme of the glycerol phosphate shuttle, are not diabetic and have normal islet glucose-induced secretion. In this study, we analyzed if environmental factors, such as a high carbohydrate diet could contribute to the development of Type 2 diabetes mellitus in mice with a specific defective genetic background.
METHODS: The mice were fed with a high carbohydrate diet for 1 and 6 months, and several biochemical parameters were analysed. The mitochondrial respiratory activity was assayed by polarography; and the islet function was studied by islet perifusion and pancreas perfusion.
RESULTS: The high carbohydrate diet induced hyperglycaemia, hyperinsulinaemia, and islet hyperplasia in the wild-type and heterozygote mice. Activity of the respiratory chain complex I also increased in these mice. In contrast, these effects were not observed in the null mice fed with the diet; in addition, these null mice had an increased insulin sensitivity compared to wild-type mice. CONCLUSION/
INTERPRETATION: The phenotype of the mice with an impairment of NADH shuttles does not worsen when fed a high carbohydrate diet; moreover, the diet does not compromise islet function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680126     DOI: 10.1007/s00125-003-1206-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

Review 1.  New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.

Authors:  A R Saltiel
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.

Authors:  K Miyawaki; Y Yamada; H Yano; H Niwa; N Ban; Y Ihara; A Kubota; S Fujimoto; M Kajikawa; A Kuroe; K Tsuda; H Hashimoto; T Yamashita; T Jomori; F Tashiro; J Miyazaki; Y Seino
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 3.  Physiology and pathology of islet metabolism.

Authors:  W J Malaisse
Journal:  Diabete Metab       Date:  1994 Mar-Apr

Review 4.  Modeling phasic insulin release: immediate and time-dependent effects of glucose.

Authors:  Rafael Nesher; Erol Cerasi
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

Review 5.  Dietary treatment of the metabolic syndrome--the optimal diet.

Authors:  G Riccardi; A A Rivellese
Journal:  Br J Nutr       Date:  2000-03       Impact factor: 3.718

6.  NADH shuttle system regulates K(ATP) channel-dependent pathway and steps distal to cytosolic Ca(2+) concentration elevation in glucose-induced insulin secretion.

Authors:  K Eto; S Suga; M Wakui; Y Tsubamoto; Y Terauchi; J Taka; S Aizawa; M Noda; S Kimura; H Kasai; T Kadowaki
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

Review 7.  Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice.

Authors:  S Seino; T Iwanaga; K Nagashima; T Miki
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

8.  Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients.

Authors:  J Fernandez-Alvarez; I Conget; J Rasschaert; A Sener; R Gomis; W J Malaisse
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

9.  Calcium activation of mitochondrial glycerol phosphate dehydrogenase restudied.

Authors:  M J MacDonald; L J Brown
Journal:  Arch Biochem Biophys       Date:  1996-02-01       Impact factor: 4.013

10.  Enzymic and metabolic anomalies in islets of diabetic rats: relationship to B cell mass.

Authors:  M H Giroix; D Baetens; J Rasschaert; V Leclercq-Meyer; A Sener; B Portha; W J Malaisse
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

View more
  6 in total

1.  Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism.

Authors:  Ahmed Alshawi; Loranne Agius
Journal:  J Biol Chem       Date:  2018-12-27       Impact factor: 5.157

2.  Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice.

Authors:  Takafumi Senmaru; Masahiro Yamazaki; Hiroshi Okada; Mai Asano; Michiaki Fukui; Naoto Nakamura; Hiroshi Obayashi; Yoshitaka Kondo; Naoki Maruyama; Akihito Ishigami; Goji Hasegawa
Journal:  J Clin Biochem Nutr       Date:  2011-11-01       Impact factor: 3.114

3.  Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.

Authors:  Anila K Madiraju; Derek M Erion; Yasmeen Rahimi; Xian-Man Zhang; Demetrios T Braddock; Ronald A Albright; Brett J Prigaro; John L Wood; Sanjay Bhanot; Michael J MacDonald; Michael J Jurczak; Joao-Paulo Camporez; Hui-Young Lee; Gary W Cline; Varman T Samuel; Richard G Kibbey; Gerald I Shulman
Journal:  Nature       Date:  2014-05-21       Impact factor: 49.962

Review 4.  Metabolic Action of Metformin.

Authors:  Izabela Szymczak-Pajor; Sylwia Wenclewska; Agnieszka Śliwińska
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-30

5.  A validated genome wide association study to breed cattle adapted to an environment altered by climate change.

Authors:  Ben J Hayes; Phil J Bowman; Amanda J Chamberlain; Keith Savin; Curt P van Tassell; Tad S Sonstegard; Mike E Goddard
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

Review 6.  Cellular and Molecular Mechanisms of Metformin Action.

Authors:  Traci E LaMoia; Gerald I Shulman
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.